Ledger.Open graph →

SEC Form D · filed August 24, 2020

Adaptive Phage Therapeutics, Inc

Offering

$7.0M

Sold

$3.4M

Exemption

Rule 506(c)

Industry

Pharmaceuticals

Location

GAITHERSBURG, MD

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (9)

Carl L. Merril · Gaithersburg, MDExec · Director William L. Mutryn · Gaithersburg, MDDirector Gregory L. Merril · Gaithersburg, MDExec · Director Matt Belcher · San Diego, CADirector Thomas Spicer · Luxembourg, LuxembourgExec · Director Maren Steinberg · DENVER, COExec · Director Tyler Engh · Chicago, ILDirector Guillermo Guefen · Houston, TXExec · Director Nick P. Steinsberger · Tulsa, OKExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗